OTCPK:ELCQ

Stock Analysis Report

Electromedical Technologies

Executive Summary

Electromedical Technologies, Inc. develops bioelectronic medicine therapy device.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • Electromedical Technologies has significant price volatility in the past 3 months.
  • No data on Electromedical Technologies's last earnings update.
  • Electromedical Technologies is not covered by any analysts.
  • No market cap data available for Electromedical Technologies.

Share Price & News

How has Electromedical Technologies's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:ELCQ

-1.2%

US Medical Equipment

1.2%

US Market


1 Year Return

n/a

OTCPK:ELCQ

8.7%

US Medical Equipment

1.7%

US Market

No trading data on ELCQ.

No trading data on ELCQ.


Share holder returns

ELCQIndustryMarket
7 Day0%-1.2%1.2%
30 Day0%1.4%4.9%
90 Dayn/a4.8%3.7%
1 Yearn/a9.6%8.7%3.9%1.7%
3 Yearn/a70.8%65.5%47.2%37.7%
5 Yearn/a130.4%104.1%60.0%42.4%

Price Volatility Vs. Market

How volatile is Electromedical Technologies's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Electromedical Technologies undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Electromedical Technologies is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Electromedical Technologies has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine Electromedical Technologies's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Electromedical Technologies regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Electromedical Technologies expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Electromedical Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Electromedical Technologies performed over the past 5 years?

0.2%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Electromedical Technologies has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Electromedical Technologies's financial position?


In this section we usually analyse Electromedical Technologies's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Electromedical Technologies has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of ELCQ’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Electromedical Technologies's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Electromedical Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Electromedical Technologies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Electromedical Technologies's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Electromedical Technologies has not reported any payouts.

Unable to verify if Electromedical Technologies's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Electromedical Technologies has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Electromedical Technologies's salary, the management and board of directors tenure and is there insider trading?


CEO

Matthew Wolfson 0

0yrs

Tenure

0

Mr. Matthew Wolfson serves as the Chief Executive Officer at Electromedical Technologies, Inc. 


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • Matthew Wolfson

    Chief Executive Officer

    • Tenure: 0yrs

Board Members

    Company Information

    Electromedical Technologies, Inc.'s company bio, employee growth, exchange listings and data sources


    Key Information

    • Name: Electromedical Technologies, Inc.
    • Ticker: ELCQ
    • Exchange: OTCPK
    • Founded: 2007
    • Industry: Health Care Equipment
    • Sector: Healthcare
    • Market Cap: US$0
    • Shares outstanding: 0
    • Website: https://electromedtech.com

    Location

    • Electromedical Technologies, Inc.
    • 16561 North 92nd Street
    • Suite 101
    • Scottsdale
    • Arizona
    • 85260
    • United States

    Listings

    TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
    ELCQOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJun 2019

    Biography

    Electromedical Technologies, Inc. develops bioelectronic medicine therapy device. The company’s products include WellnessPro Plus which is used to treat chronic and acute pain. Electromedical Technologies, ...


    Company Analysis and Financial Data Status

    All financial data provided by Standard & Poor's Capital IQ.
    DataLast Updated (UTC time)
    Company Analysis2019/09/15 00:42
    End of Day Share Price2019/08/20 00:00
    EarningsN/A
    Annual EarningsN/A


    Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.